These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 30941789)
1. Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study. de Vries ST; Denig P; Ekhart C; Burgers JS; Kleefstra N; Mol PGM; van Puijenbroek EP Br J Clin Pharmacol; 2019 Jul; 85(7):1507-1515. PubMed ID: 30941789 [TBL] [Abstract][Full Text] [Related]
2. Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands. Glerum PJ; Maliepaard M; de Valk V; Scholl JHG; van Hunsel FPAM; van Puijenbroek EP; Burger DM; Neef K Clin Transl Sci; 2020 May; 13(3):599-607. PubMed ID: 32052597 [TBL] [Abstract][Full Text] [Related]
3. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Holm L; Ekman E; Jorsäter Blomgren K Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
5. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
6. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria. Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768 [TBL] [Abstract][Full Text] [Related]
7. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014. Awodele O; Ibrahim A; Orhii P Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753 [TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions in adolescents: a review of reporting to a national pharmacovigilance system. Rebelo Gomes E; Ribeiro-Vaz I; Santos CC; Herdeiro MT Expert Opin Drug Saf; 2020 Jul; 19(7):915-922. PubMed ID: 32422079 [TBL] [Abstract][Full Text] [Related]
9. Reporting suspected adverse reactions. Diesel G; Anderson N; Ursich E Vet Rec; 2019 May; 184(20):623. PubMed ID: 31097563 [No Abstract] [Full Text] [Related]
10. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015. van Hunsel F; de Waal S; Härmark L Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293 [TBL] [Abstract][Full Text] [Related]
11. Breastfeeding-Related Adverse Drug Reactions of Triptans: A Descriptive Analysis Using Four Pharmacovigilance Databases. Conijn M; Maas V; van Tuyl M; Ceulemans M; Hendriks J; van Hunsel F; van der Mijle A Breastfeed Med; 2024 Aug; 19(8):645-651. PubMed ID: 38563407 [No Abstract] [Full Text] [Related]
12. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China. Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811 [TBL] [Abstract][Full Text] [Related]
13. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb. van Hunsel FPAM; van der Kooi D; van de Koppel S; Kroes BH; Woerdenbag HJ Drug Saf; 2022 Jun; 45(6):651-661. PubMed ID: 35608783 [TBL] [Abstract][Full Text] [Related]
15. The value of patient reporting to the pharmacovigilance system: a systematic review. Inácio P; Cavaco A; Airaksinen M Br J Clin Pharmacol; 2017 Feb; 83(2):227-246. PubMed ID: 27558545 [TBL] [Abstract][Full Text] [Related]
16. [Adverse drug reactions reported to the Brazilian pharmacovigilance system from 2008 to 2013: descriptive study]. Mota DM; Vigo Á; Kuchenbecker RS Cad Saude Publica; 2019 Aug; 35(8):e00148818. PubMed ID: 31460613 [TBL] [Abstract][Full Text] [Related]
17. Actions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands. Rolfes L; Kolfschoten J; van Hunsel F; Kooijman M; van Puijenbroek E Int J Risk Saf Med; 2016 Aug; 28(2):115-23. PubMed ID: 27567768 [TBL] [Abstract][Full Text] [Related]
18. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands. Scholl JH; van Puijenbroek EP Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554 [TBL] [Abstract][Full Text] [Related]
19. A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands. Scholl JHG; van Hunsel FPAM; Hak E; van Puijenbroek EP Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):199-205. PubMed ID: 29271017 [TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors. Ekhart C; van Hunsel F; Scholl J; de Vries S; van Puijenbroek E Drug Saf; 2018 Jul; 41(7):677-683. PubMed ID: 29484612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]